You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 147 No. 7, July 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clonidine vs Chlordiazepoxide in the Management of Acute Alcohol Withdrawal Syndrome

Gregory R. Baumgartner, MD; Randall C. Rowen, PharmD

Arch Intern Med. 1987;147(7):1223-1226.


Abstract

• To our knowledge, this is the first reported comparison of clonidine with benzodiazepine in the management of acute alcohol withdrawal syndrome. In a double-blind trial, 61 men experiencing acute alcohol withdrawal were randomly assigned to receive clonidine or chlordiazepoxide over a 60-hour treatment period. Clonidine was more effective than chlordiazepoxide at reducing alcohol withdrawal scale scores, systolic blood pressures, and heart rates over the entire study period. Clonidine was as good as chlordiazepoxide at improving Cognitive Capacity Screening Exam, Hamilton Anxiety Rating Scale, and Self-Rating Scale scores. Adverse drug reactions reported by each group were similar, though less nausea and vomiting were observed in the clonidine group. Clonidine may represent a new alternative agent for the management of acute alcohol withdrawal syndrome.

(Arch Intern Med 1987;147:1223-1226)



Author Affiliations

From the William S. Hall Psychiatric Institute, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine (Dr Baumgartner), and the Department of Pharmacy Practice, University of South Carolina College of Pharmacy (Dr Rowen), Columbia.


Footnotes

Accepted for publication Feb 25, 1987.

Reprint requests to William S. Hall Psychiatric Institute, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Box 202, Columbia, SC 29202 (Dr Baumgartner).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pharmacological Management of Alcohol Withdrawal: A Meta-analysis and Evidence-Based Practice Guideline
Mayo-Smith
JAMA 1997;278:144-151.
ABSTRACT  

Individualized Treatment of Alcohol Withdrawal-Reply
Saitz and Smith
JAMA 1995;273:183-184.
ABSTRACT  

Specificity of Ethanollike Effects Elicited by Serotonergic and Noradrenergic Mechanisms
Krystal et al.
Arch Gen Psychiatry 1994;51:898-911.
ABSTRACT  

Individualized Treatment for Alcohol Withdrawal: A Randomized Double-blind Controlled Trial
Saitz et al.
JAMA 1994;272:519-523.
ABSTRACT  

Use of Centrally Acting Sympatholytic Agents in the Management of Hypertension
Oster and Epstein
Arch Intern Med 1991;151:1638-1644.
ABSTRACT  

Impact of Clonidine on Alcohol Withdrawal States
Stock
Arch Intern Med 1988;148:241-245.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.